Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus
- PMID: 6288769
- PMCID: PMC370284
- DOI: 10.1172/jci110672
Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus
Abstract
Cytomegalovirus (CMV) is a major pathogen in the compromised host where many infections result from activation of latent virus. Because latent CMV infection has been difficult to study in humans, murine models have been developed and investigated. Here, we describe the events involved in activation of latent murine CMV (MCMV) from spleen explants in vitro. Infectious virus was no longer detectable in murine organs 4 mo after inoculatioN of 10(5) plaque-forming units of MCMV. 8-10 d after establishment of spleen explants, phagocytic macrophages covered 70-80% of the surface of tissue culture dishes, and lymphocytes were continuously released, reaching titers of 10(6) cells/ml. MCMV was produced spontaneously after 12-18 d from spleen explant cultures of 33 of 34 mice. Virus replicated to titers above 10(4) plaque-forming units/ml, remained at that level for 4-5 wk, and gradually disappeared as macrophages were lysed. Although MCMV was shown to be replicating in macrophages, these cells were never found to be the source of latent virus. Cell separation studies indicated that latent virus was initially released from 70% of lymphocyte cultures and was associated with the B cell enriched fraction. We conclude that MCMV establishes nonreplicating dormant infection in B lymphocytes, activates from these cells in spleen explant cultures, and is augmented in titer by replication in permissive macrophages.
Similar articles
-
Activation of latent murine cytomegalovirus in vivo and in vitro: a pathogenetic role for acute infection.J Infect Dis. 1982 May;145(5):699-705. doi: 10.1093/infdis/145.2.699. J Infect Dis. 1982. PMID: 6281340
-
Lethal infection with murine cytomegalovirus after early viral replication in the spleen.J Infect Dis. 1983 Sep;148(3):406-11. doi: 10.1093/infdis/148.3.406. J Infect Dis. 1983. PMID: 6311909
-
Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency.J Gen Virol. 1979 Aug;44(2):349-59. doi: 10.1099/0022-1317-44-2-349. J Gen Virol. 1979. PMID: 230287
-
Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections.J Virol. 1988 Mar;62(3):987-97. doi: 10.1128/JVI.62.3.987-997.1988. J Virol. 1988. PMID: 2828694 Free PMC article.
-
Latent infection and the elusive cytomegalovirus.Rev Infect Dis. 1983 Mar-Apr;5(2):205-15. doi: 10.1093/clinids/5.2.205. Rev Infect Dis. 1983. PMID: 6302813 Review.
Cited by
-
Animal cytomegaloviruses.Microbiol Rev. 1990 Sep;54(3):247-65. doi: 10.1128/mr.54.3.247-265.1990. Microbiol Rev. 1990. PMID: 2170830 Free PMC article. Review.
-
Focal transcriptional activity of murine cytomegalovirus during latency in the lungs.J Virol. 1999 Jan;73(1):482-94. doi: 10.1128/JVI.73.1.482-494.1999. J Virol. 1999. PMID: 9847354 Free PMC article.
-
Persistent humoral immune responses in the CNS limit recovery of reactivated murine cytomegalovirus.PLoS One. 2012;7(3):e33143. doi: 10.1371/journal.pone.0033143. Epub 2012 Mar 6. PLoS One. 2012. PMID: 22412996 Free PMC article.
-
Latent murine cytomegalovirus DNA in splenic stromal cells of mice.J Virol. 1991 Jun;65(6):3330-4. doi: 10.1128/JVI.65.6.3330-3334.1991. J Virol. 1991. PMID: 1851880 Free PMC article.
-
Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.J Virol. 1998 Jan;72(1):442-51. doi: 10.1128/JVI.72.1.442-451.1998. J Virol. 1998. PMID: 9420244 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources